ROBERT S BREUIL
CIK 1241009 · Chief Financial Officer · last filed 2023-03-27
ROBERT S BREUIL is a Chief Financial Officer who has filed 25 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for CALC, was dated Mar 27, 2023. Across all open-market trades the lifetime net is −$12.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $34.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$34.5K
3
25
-$12.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Chief Financial Officer | 48,003 | $0.72 | $34.5K | $0 | 1 | 2023-03-27 |
| CalciMedica, Inc. (GRAY) Delisted | Chief Financial Officer | 163,849 | $5.50 | $901.2K | -$28.6K | 17 | 2023-03-15 |
| Corium International, Inc. (CORI) Delisted | Chief Financial Officer | 0 | — | — | $16.0K | 7 | 2018-11-28 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-27 | CALC | Mixed | +23,980 | -$69.7K | EDGAR |
| 2023-03-15 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +3,270 | -$1.0K | EDGAR |
| 2023-03-06 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +71,783 | -$28.2K | EDGAR |
| 2022-12-14 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +3,271 | -$1.0K | EDGAR |
| 2022-12-01 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +6,501 | -$2.2K | EDGAR |
| 2022-11-29 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +18,399 | -$6.5K | EDGAR |
| 2022-09-26 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +3,316 | -$1.6K | EDGAR |
| 2022-08-26 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-23 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +6,590 | -$3.2K | EDGAR |
| 2022-06-13 | CalciMedica, Inc. (GRAY) Delisted | Exer (M) | +5,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.